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Sentinel  nodes  were  identified  using  a  combination  of 
patent blue dye (Patent Blue V; Guerbet Laboratories Ltd, 
Birmingham, UK) and radioactive tracer (99mTechnecium-


























of  the  node  onto  a  glass  slide. These  were  air-dried  and 
stained with Rapi-Diff II stain (Triangle Biomedical Sciences 
Ltd, Lancashire, UK) before being reviewed by 2 or more 
pathologists  using  a  multi-headed  microscope.  Analysis 















116  (Dako,  Glostrup,  Denmark)  using  the  avidin-biotin-
peroxidase complex method. The pathologist who prepared 
and reported the imprint was also responsible for reporting the ©  The Ulster Medical Society, 2010.





Over  an  11  month  period,  102  consecutive  patients  with 
clinically  node-negative  disease  had  SLNB  followed  by 

























sensitivity  of  80%,  a  specificity  of  100%  and  a  negative 
predictive value of 88%.
DISCUSSION
It  is  well  accepted  that  axillary  node  status  is  the  most 
important prognostic indicator in patients with invasive breast 









































sentinel  node  have  been  employed  by  different  centres 
over the past decade. Whilst there is no current “optimal” 





Once  harvested,  sentinel  nodes  undergo  a  thorough 
histopathological examination. Multisectioning rather than 
routine  bisectioning  is  known  to  decrease  the  sampling 
error  phenomenon  and  increase  metastatic  tumour 
detection6.  Other  studies  have  shown  that  cytokeratin 
immunohistochemistry  staining  also  increases  metastatic 





































As  SLNB  becomes  more  widely  used,  detection  of 
micrometastasis  in  sentinel  nodes  is  increasingly  proving 
a  therapeutic  dilemma.  The  prognostic  significance  and 
clinical  relevance  of  these  previously  occult  metastases 
is controversial11. Hansen et al examined the John Wayne 





In  contrast,  the  International  (Ludwig)  Breast  Cancer 




























Sensitivity of imprint cytology




Sensitivity of imprint 
cytology (%)
Macrometastases 41 33 80%
Micrometastases 6 2 33%©  The Ulster Medical Society, 2010.
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